CRITERIA AND CLASSIFICATION

Question 1

Diagnostic Criteria for Classical Sweet Syndrome versus Drug-Induced Sweet Syndrome

Answer 1

Question 2

Algorithm for the Diagnosis of Patch-Stage Mycosis Fungoides (4 Points Are Required)

Answer 2

Question 3

Revised Diagnostic Criteria for Hypereosinophilic Syndromes

Answer 3

Question 4

Diagnostic Criteria for Systemic Mastocytosis (Major and One Minor or Three Minor Criteria Are Needed)a

Answer 4

Question 5

SCORTEN: A Prognostic Scoring System for Patients with Epidermal Necrolysis

Answer 5

Question 6

Diagnostic Criteria for Epidermolysis Bullosa Acquisita

Answer 6

Question 7

The 1982 Revised Criteria for Classification of Systemic Lupus Erythematosusa

Answer 7

Question 8

Sontheimer’s Proposed Diagnostic Criteria for Cutaneous Dermatomyositis

Answer 8

Question 9

The Classification Criteria for PsA (CASPAR)

Answer 9

Question 10

2010 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Arthritis

Answer 10

Question 11

Adult-Onset Still Disease Criteria

Answer 11

Question 12

Diagnosis of Acute Rheumatic Fever in Patient Populations with Evidence of Preceding Group A Streptococcal Infection Using the 2015 Revised Jones Criteria

Answer 12

Question 13

Proposed Classification Criteria for Sjögren Syndrome

Answer 13

Question 14

Revised International Classification Criteria for Sjögren Syndrome

Answer 14

Question 15

Relapsing polychondritis diagnostic criteria

Answer 15

Question 16

Classical EDS (cEDS)

Answer 16

Question 17

Criteria for Skin Hyperextensibility

Answer 17

Question 18

Beighton Criteria for Joint Hypermobility

Answer 18

Question 19

Criteria for Diagnosis of Waardenburg Syndrome

Answer 19

Question 20

Subtypes of Rosacea

Answer 20

Question 21

Classification of Rosacea from 2016 and 2017: Diagnostic, Major, and Secondary Features of Rosacea

Answer 21

Question 22

Classification of Rhinophymata

Answer 22

Question 23

Classification of Ocular Rosacea

Answer 23

Question 24

Primary Focal (Essential) Hyperhidrosis

Answer 24

Question 25

Hyperhidrosis Disease Severity Scale

Answer 25

Question 26

Treatment Options for Primary Focal Hyperhidrosis

Answer 26

Question 27

Hidradenitis Suppurativa

Answer 27

Question 28

Hurley Staging of hidradenitis suppurativa

Answer 28

Question 29

Prognostic Signs of Frostbite

Answer 29

Question 30

Clinical Manifestations of Burn Injury Are Determined by Depth and Breadth of Tissue Destruction

Answer 30

Question 31

Parkland Formula for Fluid Administration in the First 24 Hours

Answer 31

Question 32

Congenital lumbosacral midline skin lesions, required assessment, and risk of occult spinal dysraphism

Answer 32

Question 33

Classification of Cutaneous Appendage Tumors

Answer 33

Question 34

Classification of Actinic Keratosis

Answer 34

Question 35

Common Basal Cell Carcinoma Subtypes with Corresponding Kodachrome

Answer 35

Question 36

Diagnostic Criteria for Basal Cell Nevus Syndrome (BCNS, Gorlin Syndrome)

Answer 36

Question 37

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Risk Factors for Local Recurrence or Metastases

Answer 37

Question 38

Clinical Features of Merkel Cell Carcinoma

Answer 38

Question 39

When to Consider Malignancy in Pigmented Nail Lesions

Answer 39

Question 40

ABCDE Checklist of Melanoma

Answer 40

Question 41

Melanoma TNM Classifications

Answer 41

Question 42

Stage Groupings for Cutaneous Melanoma

Answer 42

Question 42

Treatment algorithm of Melanoma

Answer 42

Question 43

Clinical spectrum of LCH

Answer 43

Question 44

PHACE Diagnostic Criteria

Answer 44

Question 45

Cutaneous lymphomas

Answer 45

Question 46

Algorithm for Diagnosis of Early Mycosis Fungoides

Answer 46

Question 47

Spectrum of Cutaneous Pseudolymphoma

Answer 47

Question 48

Diagnostic Criteria for Hereditary Leiomyomatosis and Renal Cell Carcinoma

Answer 48

Question 49

Histologic Criteria for the Definition of Amyloid

Answer 49

Question 50

Classification of Hyperuricemia

Answer 50

Question 51

Revised classification of acute and chronic GVHD

Answer 51

Question 52

Acute Graft-Versus-Host Disease Staging

Answer 52

Question 53

Clinical Features of Chronic Graft-Versus-Host Disease

Answer 53

Question 54

Diagnostic Criteria for Neurofibromatosis Type 1

Answer 54

Question 55

Diagnostic Criteria for Neurofibromatosis Type 2

Answer 55

Question 56

Diagnostic Criteria for Tuberous Sclerosis Complex (Updated at 2012 Conference)

Answer 56

Question 57

Definition of the Metabolic Syndrome (Any 3 of 5 Traits)

Answer 57

Question 58

International Criteria for Behçet Disease

Answer 58

Question 59

Diagnostic Criteria for Classic Kawasaki Disease

Answer 59

Question 60

Criteria for Diagnosis of Incomplete Kawasaki Disease

Answer 60

Question 61

Criteria for Primary Raynaud Phenomenon

Answer 61

Question 62

Acute Limb Ischemia: 6 Ps

Answer 62

Question 63

Classification of Infectious Folliculitis

Answer 63

Question 64

ALT-70 Risk Prediction for Cellulitis

Answer 64

Question 65

Indications for Parenteral Administration of Antibiotics

Answer 65

Question 66

Centers for Disease Control and Prevention 2011 Case Definition of Staphylococcal Toxic Shock Syndrome

Answer 66

Question 67

Proposed Cutaneous Variants of Necrotizing Fasciitis

Answer 67

Question 68

Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) Score

Answer 68

Question 69

Factors Found in Literature to Be Associated with a High Mortality Risk in Patients with Necrotizing Fasciitis

Answer 69

Question 70

Modified Duke Criteria for Infective Endocarditis

Answer 70

Question 71

Classification of Cutaneous Tuberculosis

Answer 71